HSIC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Henry Schein Inc (HSIC) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company has shown strong financial performance, positive analyst sentiment, and optimistic growth guidance for 2026. Despite the lack of immediate trading signals, the overall outlook supports a long-term investment.
The stock exhibits bullish moving averages (SMA_5 > SMA_20 > SMA_200), indicating an upward trend. The MACD is positive at 0.368, though contracting, and the RSI is neutral at 59.869. Key support and resistance levels are S1: 76.659, Pivot: 81.671, and R1: 86.683. The technical indicators suggest a stable upward trend with room for growth.
Strong Q4 2025 financial results with revenue up 7.71% YoY and EPS up 13.33% YoY.
Positive analyst sentiment with multiple price target increases, including an upgrade to Outperform by Baird.
Optimistic growth guidance for 2026 and a new CEO appointment, which may drive strategic improvements.
Strong demand for specialty products and global distribution sales growth.
Gross margin dropped slightly by -0.75% YoY in Q4
The stock's short-term trend suggests a potential minor decline (-0.5% in the next day, -0.94% in the next week), though this is not significant for long-term investors.
In Q4 2025, Henry Schein reported revenue of $3.44 billion (up 7.71% YoY), net income of $101 million (up 7.45% YoY), and EPS of $0.85 (up 13.33% YoY). Despite a slight decline in gross margin to 28.92%, the company's financials reflect strong growth trends and a positive outlook for 2026.
Analysts have raised price targets significantly, with the highest target at $104 (Baird) and multiple upgrades to Outperform. The consensus reflects confidence in the company's growth potential, particularly in the dental sector and specialty products. Recent upgrades and price target increases are based on better-than-expected Q4 results and improved growth visibility.
